Keywords: gsk, ph, iii, entereg, trial, completes, enrollment

GSK's Ph III Entereg trial completes enrollment

Article | 24 April 2006

Print This

UK drug major GlaxoSmithKline has completed enrollment of a Phase III clinical program to evaluate the efficacy and safety of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in